Related Experiment Video
Updated: May 11, 2026
08:31
Versatility of Protocols for Resistance Training and Assessment Using Static and Dynamic Ladders in Animal Models
Published on: December 17, 2021
RIGOR guidelines: escalating STAIR and STEPS for effective translational research.
Paul A Lapchak1, John H Zhang, Linda J Noble-Haeusslein
1Department of Neurology, Cedars-Sinai Medical Center, Davis Research Building, D-2091, 110 N. George Burns Road, Los Angeles, CA 90048 USA.
Translational Stroke Research
|May 10, 2013
Summary
Developing effective stroke treatments requires rigorous laboratory practices and transparent reporting. Implementing guidelines like blinding, randomization, and power analysis is crucial for successful translational research in stroke therapies.
Area of Science:
- Neuroscience
- Translational Medicine
- Biomedical Research
Background:
- Stroke remains a major global health challenge, necessitating improved therapeutic strategies.
- Current treatment development faces hurdles in translating preclinical findings to clinical success.
Observation:
- Effective stroke therapies require robust laboratory practices and transparent reporting.
- Translational research models must accurately represent stroke pathology for reliable results.
Findings:
- Key guidelines for translational stroke research include study blinding, randomization, and power analysis.
- Accurate statistical analysis and conflict of interest disclosures are essential for research integrity.
- Reproducibility and efficacy confirmation across multiple species are vital for validating new treatments.
Implications:
- Adherence to these guidelines can accelerate the development of effective treatments for ischemic and hemorrhagic stroke.
- Improved translational research practices will enhance the reliability and clinical applicability of stroke therapies.
- This framework supports the creation of innovative and efficacious therapies for stroke patients worldwide.
